Pfizer adds ex-State Street CEO to the board; Two Merus execs head for the exit

A few comings and goings before the Independence Day holiday in the US:

Cyrus Taraporevala

Pfizer has welcomed former State Street Global Advisors president and CEO Cyrus Taraporevala to the board of directors. Taraporevala retired from State Street in 2022, and he has board seats at Shell and Bridgepoint Group. With another $1.5 billion in cost cuts coming down the pike, Pfizer is gearing up for its second-quarter earnings report after CEO Albert Bourla called its Q1 performance “phenomenal,” according to CNBC.

Andrew Joe

Merus was one of the big winners from this year’s ASCO conference, drawing buzz for positive Phase 2 data from its petosemtamab/Keytruda combo for head and neck squamous cell carcinoma and raising $400 million in…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks